Zimmer Biomet Holdings, Inc. ZBH recently received Food and Drug Administration (“FDA”) Premarket Approval Application (“PMA”) Supplement approval for the Oxford Cementless Partial Knee.

Patrick Peavy, MD, an orthopedic surgeon at Birmingham-based OrthoAlabama Spine & Sports, performed the first Oxford Cementless Partial Knee replacement surgery in Alabama. The FDA-approved procedure ...

Objective To assess the benefit of arthroscopic partial meniscectomy (APM) in adults with a meniscal tear and knee pain in three defined populations ... DRF-2017-10-030) and Oxford NIHR Biomedical ...

Image Source: Zacks Investment Research Last month, Zimmer Biomet received FDA Premarket Approval Application (“PMA”) Supplement approval for the Oxford Cementless Partial Knee. The approval ...